Vogt‐Koyanagi‐Harada disease‐like posterior uveitis in the course of nivolumab (anti‐PD‐1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma

A patient with metastatic cutaneous malignant melanoma developed Vogt‐Koyanagi‐Harada disease‐like posterior uveitis after two nivolumab (anti‐PD‐1 antibody) injections. Vogt‐Koyanagi‐Harada disease, with the background of autoimmunity against choroidal melanocytes, suggests nivolumab be working by...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Toshihiko, Yamasaki, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412830/
https://www.ncbi.nlm.nih.gov/pubmed/28469878
http://dx.doi.org/10.1002/ccr3.911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412830/
https://www.ncbi.nlm.nih.gov/pubmed/28469878
http://dx.doi.org/10.1002/ccr3.911

Ejemplares similares